CB2 Insights Announces Record Annual Revenue of $13.4 million for FY 2019 Sequential Growth of 25%

— CB2 Insights (CSE: CBII; OTCQB: CBIIF) (“CB2” or the “Company”), one of the largest integrative healthcare system in the United States, today reported its audited consolidated financial results for the year ended December 31, 2019. Additional information concerning the Company, including its unaudited condensed consolidated interim financial statements and related management’s discussion and analysisContinue reading “CB2 Insights Announces Record Annual Revenue of $13.4 million for FY 2019 Sequential Growth of 25%”

CB2 Insights Announces Amendments to Promissory Note held by Merida Capital Partners

“CB2 is one of those rare companies that has grown into a profitable enterprise in the cannabis landscape.” CB2 Insights (CSE: CBII; OTCQB: CBIIF), announces that it has amended the terms of its issued and outstanding promissory note held by Merida Capital Partners (“Merida”), which is designed to help the Company achieve its long termContinue reading “CB2 Insights Announces Amendments to Promissory Note held by Merida Capital Partners”